Constellation Brands, Inc.

NYSE: STZ
$184.93
+$2.54 (+1.4%)
Closing price July 10, 2020
Marijuana stocks have suffered a terrible beating in the past year or so. Here's a look at six former high-flyers and their prospects for a recovery.
With stocks surging at the start of July and with COVID-19 cases rising rapidly in America, the economy finds itself in a bit of a jam. It seems impossible to rationalize that the largest technology...
Thursday's top analyst upgrades and downgrades included Activision Blizzard, Akamai Technologies, Avis Budget, BlackRock, Consolidated Edison, DocuSign, Livongo Helath, Nu Skin Enterprises, Rio Tinto...
BofA Securities has made huge changes to its US 1 list of top stocks to buy. These five additions should fare well in the second half of 2020.
FedEx, Macy's, Micron Technology and others are scheduled to share their most recent quarter results this week. Here's what to expect.
Tuesday's top analyst upgrades and downgrades included BHP, Electronic Arts, Gilead Sciences, Immunomedics, KeyCorp, Peloton Interactive, Shopify, Sunnova Energy, Take-Two Interactive and Walt Disney.
While investors have been pounded with horrible job loss and unemployment data, Stifel is calling for a rally into the end of April. Here are some solid picks in what remains dangerous and uncharted...
Constellation Brands reported better than expected fiscal fourth-quarter financial results before the markets opened on Friday.
We are in the earnings doldrums right now, but a few more major companies will be sharing their results soon, including Walgreens and CarMax.
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
Canadian marijuana grower Canopy Growth reported fiscal third-quarter results Friday morning that were better on both the top and bottom lines than analysts had expected. The company is making...
The cannabis industry got another shock when Aurora Cannabis announced that its founder and chief executive, Terry Booth, would retire. He is the third high-profile CEO of a cannabis company to lose...
Investors of Aurora Cannabis, like investors everywhere, are an impatient lot. Wall Street expects profits, and none of these marijuana companies is anywhere near profitability.
As the bad news piled up for CannTrust last year, the rest of the cannabis industry also imploded. What to expect from CannTrust in 2020 is a glass either half-empty or half-full.
It's a wonder that Ontario-based Aphria survived 2019 at all. Now that it has, what can investors look forward to in 2020?